What is BJDX's earnings growth forecast for 2026-2026?
(NASDAQ: BJDX) Bluejay Diagnostics's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Bluejay Diagnostics's earnings in 2026 is -$20,073,714.
In 2026, BJDX is forecast to generate -$134,155 in earnings, with the lowest earnings forecast at -$128,894 and the highest earnings forecast at -$138,101.
What is BJDX's revenue growth forecast for 2026-2026?
(NASDAQ: BJDX) Bluejay Diagnostics's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Bluejay Diagnostics's revenue in 2026 is $0.
In 2026, BJDX is forecast to generate $3,636,881 in revenue, with the lowest revenue forecast at $3,494,472 and the highest revenue forecast at $3,743,915.
What is BJDX's forecast return on assets (ROA) for 2026-2026?
(NASDAQ: BJDX) forecast ROA is -2.74%, which is lower than the forecast US Medical Devices industry average of 10.02%.
What is BJDX's Earnings Per Share (EPS) forecast for 2026-2026?
(NASDAQ: BJDX) Bluejay Diagnostics's current Earnings Per Share (EPS) is -$116.14. In 2026, BJDX's EPS is forecast to hit -$0.30 (min: -$0.28, max: -$0.30).
What is BJDX's forecast return on equity (ROE) for 2026-2026?
(NASDAQ: BJDX) forecast ROE is -3.63%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.